Global RNA Synthesis Market Strategic Research Report

Scope of the Report

The global RNA Synthesis market size is predicted to grow from US$ 2,788 million in 2025 to US$ 6,551 million in 2032; it is expected to grow at a CAGR of 12.9% from 2026 to 2032.

RNA synthesis refers to the products and services provided by suppliers, based on customer-specified RNA sequences, structural modifications, lengths, purity, quality grades, and delivery specifications. These processes include chemical solid-phase phosphorous acid synthesis, liquid-phase/enzymatic ligation, in vitro transcription, capping, tailing, purification, analytical detection, and GMP quality control. The synthesis produces ordinary RNA, modified RNA, RNA oligonucleotides, siRNA, miRNA, sgRNA, crRNA, tracrRNA, mRNA, saRNA, circRNA, RNA/DNA chimeras, RNA aptamers, and related RNA-based drug raw materials.

From a demand structure perspective, the growth in RNA synthesis comes from two directions: first, the routine demand for short-chain, modified, and high-purity RNA oligos from research and diagnostics; and second, the incremental demand from the therapeutic end for the synergistic development of GMP small nucleic acids, mRNA, saRNA, circRNA, and delivery formulations. The commercialization of RNAi drugs has validated the clinical value of small nucleic acid routes such as siRNA, CRISPR applications are driving demand for sgRNA, crRNA, and long RNA, and mRNA vaccine platforms are promoting upgrades in IVT, capping, purification, dsRNA impurity control, and LNP encapsulation capabilities.

This report presents a comprehensive overview of the global RNA Synthesis market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Transcription
• RNA Replication

Segment by Product Function

• Coding RNA
• Non-coding RNA

Segment by Synthesis Rate

• 20~40 nt/s
• 40~100 nt/s
• ＞100 nt/s

Segment by Application

• Biomedicine
• Molecular Diagnostics
• Agriculture
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global RNA Synthesis market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Biomedicine, Molecular Diagnostics, Agriculture evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact